This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Changes
Gerald D. Fischbach, MD, was named Columbia University’s Vice President for Health and Biomedical Sciences, effective February 2001. Dr. Fischbach comes from the NIH where he had been the director of the National Institute of Neurological Disorders and Stroke (NINDS) since 1998. At Columbia, Dr. Fischbach will head a division that includes four health science professional schools and 27 academic departments.
Gerald D. Fischbach
Of his new position, Fischbach stated: “This is an extraordinary time in biomedical and health sciences. Advances at all levels of analysis, ranging from molecules to behavior, have begun to revolutionize the practice of medicine. Investigators throughout Columbia have contributed enormously to this revolution. It is a privilege to join this distinguished faculty and help shape its course in the coming years.”
Solomon “Nico” L. Moshe, MD, was elected president of the American Epilepsy Society (AES) in December 2000. Dr. Moshe is a professor of neurology, neuroscience, and pediatrics at the Albert Einstein College of Medicine in New York. An internationally renowned physician and scientist, his research focuses on the causes of age-related differences in epilepsy and on the effect of seizures on the developing brain.
Solomon L. Moshe
Robert S. Fisher, MD, PhD, is now chief of the Stanford Comprehensive Epilepsy Center and Maslah Saul, MD, professor of neurology at Stanford Medical Center. Dr. Fisher comes from the Barrow Neurological Institute where he was chair of neurology. Dr. Fisher is a leading expert in the field of epilepsy and has held prominent positions such as president of the American Epilepsy Society and the Epilepsy Foundation of Arizona. When asked what it felt like …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa